Envista Holdings Corp - Understand $nvst stock

$NVST Market Cap: $3.54 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$2.503B

TTM

Gross Margin

53.39%

TTM

Net Earnings

-$1.337B

TTM

Current Assets

$1.797B

Q3 2024

Current Liabilities

$865.5M

Q3 2024

Current Ratio

207.63%

Q3 2024

Total Assets

$5.511B

Q3 2024

Total Liabilities

$2.321B

Q3 2024

Book Value

$3.190B

Q3 2024

Cash

$991.3M

Q3 2024

P/E

-2.647

Nov 29, 2024 EST

Free Cash Flow

$272.7M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$2.567B	$2.569B	$2.509B	$1.929B	$2.285B	$2.845B	$2.811B	$2.785B	$2.736B
YoY Change	-0.1%	2.4%	30.06%	-15.57%	-19.68%	1.2%	0.92%	1.79%	24.77%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$2.567B	$2.569B	$2.509B	$1.929B	$2.285B	$2.845B	$2.811B	$2.785B	$2.736B
Cost Of Revenue	$1.126B	$1.094B	$1.082B	$874.3M	$935.6M	$1.243B	$1.190B	$1.184B	$1.214B
Gross Profit	$1.441B	$1.475B	$1.427B	$1.055B	$1.349B	$1.602B	$1.621B	$1.601B	$1.522B
Gross Profit Margin	56.13%	57.41%	56.86%	54.68%	59.05%	56.31%	57.68%	57.48%	55.62%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Selling, General & Admin	$1.057B	$1.056B	$1.020B	$924.6M	$980.4M	$1.131B	$1.062B	$1.056B	$1.038B
YoY Change	0.13%	3.5%	10.3%	-5.69%	-13.35%	6.51%	0.63%	1.68%	42.19%
% of Gross Profit	73.37%	71.57%	71.49%	87.66%	72.67%	70.63%	65.52%	65.92%	68.21%
Research & Development	$93.80M	$100.1M	$100.5M	$86.70M	$133.1M	$172.0M	$172.4M	$142.8M	$133.8M
YoY Change	-6.29%	-0.4%	15.92%	-34.86%	-22.62%	-0.23%	20.73%	6.73%	62.38%
% of Gross Profit	6.51%	6.79%	7.05%	8.22%	9.87%	10.74%	10.63%	8.92%	8.79%
Depreciation & Amortization	$135.6M	$137.8M	$117.8M	$121.7M	$120.4M	$130.0M	$121.4M	$127.2M
YoY Change	-1.6%	16.98%	-3.2%	1.08%	-7.38%	7.08%	-4.56%
% of Gross Profit	9.41%	9.34%	8.26%	11.54%	8.92%	8.12%	7.49%	7.94%
Operating Expenses	$1.151B	$1.156B	$1.120B	$1.011B	$1.114B	$1.303B	$1.235B	$1.198B	$1.172B
YoY Change	-0.42%	3.15%	10.78%	-9.18%	-14.57%	5.57%	3.03%	2.25%	44.23%
Operating Profit	$289.8M	$319.2M	$306.2M	$43.50M	$235.7M	$298.4M	$386.6M	$402.8M	$350.0M
YoY Change	-9.21%	4.25%	603.91%	-81.54%	-21.01%	-22.81%	-4.02%	15.09%	16.28%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Interest Expense	-$63.40M	$38.40M	$54.10M	$62.50M	$3.500M	$0.00	$0.00
YoY Change	-265.1%	-29.02%	-13.44%	1685.71%
% of Operating Profit	-21.88%	12.03%	17.67%	143.68%	1.48%	0.0%	0.0%
Other Income/Expense, Net	-$23.00M	$3.100M	$2.400M	-$1.000M	$1.500M	$2.700M	$100.0K	-$1.100M	$500.0K
YoY Change	-841.94%	29.17%	-340.0%	-166.67%	-44.44%	2600.0%	-109.09%	-320.0%	-138.46%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015
Pretax Income	-$54.90M	$283.9M	$254.5M	-$20.00M	$233.7M	$301.1M	$386.7M	$401.7M	$350.5M
YoY Change	-119.34%	11.55%	-1372.5%	-108.56%	-22.38%	-22.14%	-3.73%	14.61%	16.95%
Income Tax	$45.30M	$45.90M	-$9.000M	-$62.50M	$49.60M	$70.40M	$85.60M	$129.7M	$75.00M
% Of Pretax Income		16.17%	-3.54%		21.22%	23.38%	22.14%	32.29%	21.4%
Net Earnings	-$100.2M	$243.1M	$340.5M	$33.30M	$217.6M	$230.7M	$301.1M	$272.0M	$275.5M
YoY Change	-141.22%	-28.6%	922.52%	-84.7%	-5.68%	-23.38%	10.7%	-1.27%	35.18%
Net Earnings / Revenue	-3.9%	9.46%	13.57%	1.73%	9.52%	8.11%	10.71%	9.77%	10.07%
Basic Earnings Per Share	-$0.60	$1.49	$2.11	$0.21	$1.60	$1.80	$2.35
Diluted Earnings Per Share	-$0.60	$1.37	$1.92	$0.20	$1.60	$1.80	$2.35	$1.759M	$1.782M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017
Cash & Short-Term Investments	$940.0M	$606.9M	$1.074B	$888.9M	$211.2M
YoY Change	54.89%	-43.47%	20.78%	320.88%
Cash & Equivalents	$940.0M	$606.9M	$1.074B	$888.9M	$211.2M
Short-Term Investments
Other Short-Term Assets	$137.4M	$123.4M	$166.5M	$73.70M	$69.20M	$48.30M	$55.70M
YoY Change	11.35%	-25.89%	125.92%	6.5%	43.27%	-13.29%
Inventory	$258.8M	$300.8M	$263.8M	$266.9M	$277.9M	$278.7M	$275.7M
Prepaid Expenses
Receivables	$407.5M	$393.5M	$331.9M	$361.0M	$443.6M	$459.8M	$463.1M
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.744B	$1.425B	$1.836B	$1.591B	$1.002B	$786.8M	$794.5M
YoY Change	22.4%	-22.4%	15.42%	58.75%	27.34%	-0.97%
Property, Plant & Equipment	$434.7M	$425.4M	$392.2M	$468.3M	$490.4M	$261.6M	$231.2M
YoY Change	2.19%	8.47%	-16.25%	-4.51%	87.46%	13.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$180.5M	$153.7M	$167.8M	$127.3M	$74.40M	$77.40M	$81.20M
YoY Change	17.44%	-8.4%	31.81%	71.1%	-3.88%	-4.68%
Total Long-Term Assets	$4.861B	$5.162B	$4.738B	$5.286B	$5.156B	$5.055B	$5.198B
YoY Change	-5.83%	8.95%	-10.35%	2.5%	2.01%	-2.76%
Total Assets	$6.605B	$6.587B	$6.574B	$6.876B	$6.158B	$5.842B	$5.993B
YoY Change
Accounts Payable	$179.5M	$228.3M	$185.8M	$235.1M	$208.0M	$217.4M	$222.4M
YoY Change	-21.38%	22.87%	-20.97%	13.03%	-4.32%	-2.25%
Accrued Expenses	$486.0M	$377.4M	$458.2M	$465.4M	$412.3M	$358.9M	$330.9M
YoY Change	28.78%	-17.63%	-1.55%	12.88%	14.88%	8.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$886.8M	$3.900M	$0.00	$0.00
YoY Change			-100.0%	22638.46%
Long-Term Debt Due	$115.3M	$510.0M	$432.4M	$886.8M	$3.900M
YoY Change	-77.39%	17.95%	-51.24%	22638.46%
Total Short-Term Liabilities	$780.8M	$1.237B	$1.208B	$1.685B	$709.2M	$641.0M	$628.2M
YoY Change	-36.86%	2.36%	-28.28%	137.55%	10.64%	2.04%
Long-Term Debt	$1.398B	$870.7M	$883.4M	$907.7M	$1.321B	$0.00	$0.00
YoY Change	60.57%	-1.44%	-2.68%	-31.29%
Other Long-Term Liabilities	$252.3M	$272.7M	$424.6M	$562.6M	$585.3M	$374.2M	$370.0M
YoY Change	-7.48%	-35.77%	-24.53%	-3.88%	56.41%	1.14%
Total Long-Term Liabilities	$1.650B	$1.143B	$1.308B	$1.470B	$1.906B	$374.2M	$370.0M
YoY Change	44.34%	-12.58%	-11.04%	-22.87%	409.43%	1.14%
Total Liabilities	$2.431B	$2.380B	$2.517B	$3.155B	$2.618B	$1.019B	$1.002B
YoY Change	2.15%	-5.42%	-20.24%	20.52%	157.05%	1.62%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017
Basic Shares Outstanding	166.9M shares	162.9M shares	161.2M shares	159.6M shares	136.2M shares	127.9M shares	127.9M shares
Diluted Shares Outstanding	166.9M shares	177.6M shares	177.6M shares	164.1M shares	136.4M shares	127.9M shares	127.9M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $3.54 Billion

About Envista Holdings Corp

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The company went IPO on 2019-09-18. The firm provides dental consumables, solutions, technology, and services. The company has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The firm operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

Industry: Dental Equipment & Supplies Peers: ABBOTT LABORATORIES QuidelOrtho Corp GLOBUS MEDICAL INC Inspire Medical Systems, Inc. MASIMO CORP OMNICELL, INC. Penumbra Inc Shockwave Medical, Inc. TELEFLEX INC